National Cancer Institute LAO
2 clinical trials · Sponsor
◉ Watch National Cancer Institute LAO
| Record | Firm | Date |
|---|---|---|
| Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma (NCT05836571) | National Cancer Institute LAO | 2023-10-25 |
| Collection and Storage of Tissue and Blood Samples From Patients With Cancer (NCT02474160) | National Cancer Institute LAO | 2015-05-19 |
Track National Cancer Institute LAO automatically
Every clearance here is in the API, with alerts when new ones post.